• Contact Us
  • Login
Subscribe
LittleAfrica News
  • Home
  • Trump Admin
  • NYC 2025 Elections
    • Public Advocate Candidates Forum
    • Comptroller Candidates Forum
    • Meet The Candidates Video Interview Series
  • Metro
  • U.S.
  • International
    • Africa
    • Caribbean
    • Europe
    • Latin America
  • Podcasts
No Result
View All Result
  • Home
  • Trump Admin
  • NYC 2025 Elections
    • Public Advocate Candidates Forum
    • Comptroller Candidates Forum
    • Meet The Candidates Video Interview Series
  • Metro
  • U.S.
  • International
    • Africa
    • Caribbean
    • Europe
    • Latin America
  • Podcasts
No Result
View All Result
LittleAfrica News
No Result
View All Result
Home News U.S.

Louisiana Reclassifies Abortion Pills as Controlled Substances, Sparking Health Concerns

Tamara Brown by Tamara Brown
October 1, 2024
in Crime and Public Safety, Politics, U.S.
Louisiana Reclassifies Abortion Pills as Controlled Substances, Sparking Health Concerns
0
SHARES
Share on FacebookShare on Twitter

A new law took effect in Louisiana that reclassifies the abortion pills mifepristone and misoprostol as Schedule IV controlled substances, a category typically reserved for drugs with potential for abuse. The law, which took effect on Tuesday, October 1st, has raised concerns among healthcare providers, who warn that it could delay lifesaving care for women, particularly in cases of miscarriage, postpartum hemorrhage, and labor complications. The drugs are frequently used in medical procedures beyond abortion, and restricting access could have serious implications for women’s health.

Louisiana, which already has a near-total abortion ban, passed this law to restrict access to medication abortion further. However, medical professionals, such as Dr. Jennifer Avegno, Director of the New Orleans Health Department, argue that the classification was driven by a moral agenda rather than medical science. Avegno emphasized that these drugs are critical for managing various pregnancy-related conditions, including inducing labor and preventing life-threatening hemorrhages. The new law could force hospitals to store the drugs in locked cabinets, potentially delaying emergency treatment by several minutes in critical situations.

Under the law, possessing the medications without a prescription is punishable by up to five years in prison, though pregnant women are exempt from criminal penalties. Healthcare providers worry that the increased oversight could discourage pharmacists from filling prescriptions, leading to delays in care. Dr. Nicole Freehill, an OB-GYN in Louisiana, stated that time is crucial in emergency situations like postpartum hemorrhage, where even a two-minute delay could have fatal consequences.

Anti-abortion advocates, such as Louisiana Right to Life, maintain that physicians will still have access to medications for medical emergencies. However, many medical professionals believe the law will create confusion and fear among healthcare workers, hindering the timely use of these medications. Nurse Tamika Thomas-Magee from Planned Parenthood Gulf Coast expressed concerns that the law would disproportionately affect Black women, who already face higher maternal mortality rates in the state.

Doctors have raised concerns that the law is part of a broader effort by anti-abortion groups to limit access to abortion pills, which are used in two-thirds of U.S. abortions. Despite this, the medical community emphasizes that mifepristone and misoprostol are essential in treating various conditions unrelated to abortion, and reclassifying them as controlled substances could have dangerous consequences for women’s health.

Related Posts

Venezuelan Opposition Leader María Corina Machado Wins Nobel Peace Prize
International

Venezuelan Opposition Leader María Corina Machado Wins Nobel Peace Prize

October 10, 2025
0
Judge Rejects Abrego Garcia’s Request to Reopen Immigration Case
Immigration

Judge Rejects Abrego Garcia’s Request to Reopen Immigration Case

October 2, 2025
0
U.S. Government Shutdown Begins After Senate Rejects Funding Proposals
Trump Administration

U.S. Government Shutdown Begins After Senate Rejects Funding Proposals

October 1, 2025
0
Trump Says He Won’t Fund Mamdani’s ‘Fake Communist Promises’
NYC 2025 Elections

Trump Says He Won’t Fund Mamdani’s ‘Fake Communist Promises’

September 29, 2025
0
Trump Imposes Tariffs and Visa Sanctions on Colombia Over Deportation Flight Refusal
Trump Administration

Trump Imposes 100% Tariff on Foreign-Made Movies

September 29, 2025
0

Bangladeshi Leader Endorses Cuomo for Mayor

https://www.littleafricanews.com/wp-content/uploads/2025/10/Cuomo-and-Fahad-Solaiman-at-masjid.mp4
LittleAfrica News Logo

Local, National, and International News for the Diaspora

BOMESI - Black Owned Media Equity and Sustainability Institute

Recent Posts

  • New Jersey School Board Candidate Quits After Leaked Texts Target Member
  • Venezuelan Opposition Leader María Corina Machado Wins Nobel Peace Prize
  • New York Attorney General Letitia James Indicted on Bank Fraud Charge
  • Cuomo Rises 10 Points in Latest Poll as NYC Mayoral Contest Tightens
  • Israel and Hamas Agree on First Phase of Gaza Ceasefire, Hostages Set to Be Released

Menu

  • Home
  • Trump Admin
  • NYC 2025 Elections
    • Public Advocate Candidates Forum
    • Comptroller Candidates Forum
    • Meet The Candidates Video Interview Series
  • Metro
  • U.S.
  • International
    • Africa
    • Caribbean
    • Europe
    • Latin America
  • Podcasts

© 2025 LittleAfrica News. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • About Us
  • Contact Us
  • Home
  • Letters to the Editor
  • Mona Davids, Founder and Publisher
  • Mymoena Kalinisan-Davids, Director of Communications and Editor-in-Chief
  • Newspaper Digital Editions

© 2025 LittleAfrica News. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?